ArticleNature medicine2025

Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity.

Hamlet Gasoyan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.